Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report
1 Department of Oncology-Hematology, Cantonal Hospital, St.Gallen, Switzerland
2 Oncological Palliative Medicine, Cantonal Hospital, St.Gallen, Switzerland
3 Department of Dermatology, Cantonal Hospital, St.Gallen, Switzerland
4 Department of Plastic-Surgery, Cantonal Hospital, St.Gallen, Switzerland
5 Department of Radiation Therapy, Cantonal Hospital, St.Gallen, Switzerland
Journal of Medical Case Reports 2009, 3:93 doi:10.1186/1752-1947-3-93Published: 2 November 2009
Radiation recall dermatitis is a well known but still poorly understood inflammatory reaction. It can develop in previously irradiated areas and has been shown to be triggered by a variety of different drugs, including cytostatic agents. Pemetrexed may cause radiation recall dermatitis in pre-irradiated patients.
We present the case of a 49-year-old Caucasian woman with non-small cell lung cancer who was initially treated with carboplatin and paclitaxel concomitant with radiotherapy after suffering a painful plexus brachialis infiltration. Due to disease progression, a second-line treatment with pemetrexed was started. A severe soft tissue necrosis developed despite steroid treatment and plastic surgery.
To the best of our knowledge, we present the first case of a patient with severe soft tissue necrosis in a pre-irradiated area after pemetrexed therapy. We believe that physicians treating patients with pemetrexed should be aware of the severe, possibly life-threatening effects that may be induced by pemetrexed after previous radiation therapy.